Showing results (141-150 of 232) with videos related to

Sort By:
Pageof 24
Biochimica Et Biophysica Acta|February 22, 2012
Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)β)-knockout miceYewon Cheon, Hyung-Wook Kim, Miki Igarashi, et al.
Brain, Behavior, & Immunity - Health|February 3, 2025
Lipid mediators in post-mortem brain samples from patients with Alzheimer's disease: A systematic reviewAidan D Tyrrell, Giulia Cisbani, Mackenzie E Smith, et al.
Metabolites|June 27, 2023
Associations between Plasma Lipid Mediators and Chronic Daily Headache Outcomes in Patients Randomized to a Low Linoleic Acid Diet with or without Added Omega-3 Fatty AcidsQing Shen, Jun Yang, Daisy Zamora, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 14, 2020
Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: Can they help predict risk of preterm birth?Christopher E Ramsden, Maria Makrides, Zhi-Xin Yuan, et al.
Health Care Management Science|January 4, 2022
Bibliometric analysis of cancer care operations management: current status, developments, and future directionsMajed Hadid, Adel Elomri, Tarek El Mekkawy, et al.
Cancer Reports (Hoboken, N.J.)|July 5, 2024
Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomesHesham Elsabah, Rola Ghasoub, Dina S Soliman, et al.
Epilepsy Research|January 31, 2012
Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher dosesMarc-Olivier Trépanier, Ameer Y Taha, Rebecca L Mantha, et al.
Epilepsy & Behavior : E&B|March 26, 2014
Intraperitoneal administration of docosahexaenoic acid for 14days increases serum unesterified DHA and seizure latency in the maximal pentylenetetrazol modelMarc-Olivier Trépanier, Joonbum Lim, Terence K Y Lai, et al.
Chemmedchem|October 29, 2017
Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase InhibitorsHazem Abdelkarim, Raghupathi Neelarapu, Antonett Madriaga, et al.
Journal of Health Economics and Outcomes Research|July 22, 2024
Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf CountriesAnas Hamad, Shereen Al-Azzazy, Ruba Y Taha, et al.
Pageof 24